Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Combination therapy with Finasteride is more effective than alpha-blocker alone for BPH symptoms in small prostate volume.

Tamsulosin is a cost-effective treatment for BPH symptoms.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Digital health technology improves health and medication adherence in kidney transplant patients.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Androgens may influence bladder cancer progression by affecting cellular behavior.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Finasteride can reliably cause hypospadias in rabbits.

The lowest effective dose of Botox for detrusor sphincter dyssynergia is between 75-100 units.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Taking finasteride for over a month before surgery reduces blood loss during TURP.

Self-management can help improve symptoms of benign prostatic hyperplasia.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Dutasteride is more effective than finasteride in reducing urinary retention and surgery risks in people aged 65 and older.

Tamsulosin increases the risk of floppy iris during eye surgery.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Testosterone increases certain proteins in the uterus, reducing fluid volume.

BPH management needs better long-term studies and prevention strategies.

Tamsulosin and finasteride together effectively slow down and prevent BPH progression.

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.